Former Obama campaign staffer questions feasibility of Democrats' 'Medicare-for-all' plan
More than a hundred House Democrats are pushing for a bill to expand Medicare coverage.
Bayer now faces 11,200 lawsuits over Roundup cancer risk
More than 1,900 lawsuits have popped up over the past three months alone.
Suit: Missouri professor stole and sold student's research
The University of Missouri is suing a pharmacy professor at its Kansas City campus over allegations he stole and sold a student's research, claiming that the school is the rightful owner of the work it believes could be used to make a billion-dollar drug.
Medicare-for-all bill: Why you should be very concerned
The promise of completely ‘free’ medical care of every sort imaginable should sound too good to be true. (Because it is.)
Democrats unveil sweeping Medicare-for-all health care overhaul
The bill has more than 100 Democratic supporters in the House.
Nicotine-infused toothpicks use among teenagers raising concerns
Concerns over nicotine-infused toothpicks
AOC, Sanders, Warren, Robert Reich (and socialism) are nothing to joke about
The problem is -- and we are not kidding -- if you confiscated every dime earned by every person in this country, it would not pay for these agendas.
Asian shares higher as region eyes Trump-Kim summit
The stock market shook off an early slump and was mixed in morning trading Tuesday as investors weighed conflicting reports on how the U.S. economy is doing.
Drug prices can be lowered by reforming rebate program: BIO CEO Jim Greenwood
The Biotechnology Innovation Organization CEO and former Congressman says drug prices can be lowered by reforming the rebate program.
Big pharma relies on old talking points to battle new scrutiny
Tuesday's hearing will likely not be the last congressional appearance by drug executives.
Pharmaceutical industry CEOs face Senate hearing on prices
The executives will represent companies with some of the highest-grossing drugs in the world, and have routinely raised prices on many of their products.
Meet the Big Pharma CEOs testifying before the Senate
Collectively, the executives earned more than $63 million in 2017 while raising the prices on many of their popular drugs.
Roche buying Spark Therapeutics as firm seeks new patients for landmark drug
The deal comes as big pharma rushes to get in on burgeoning gene therapy treatments.
GE sells biopharma unit for $21 billion
General Electric is selling its biopharma business to Danaher Corp. for $21.4 billion as the industrial giant continues to shed pieces of itself.
General Electric Co. to sell its biopharma business to Danaher for $21 billion in cash, plus pension obligations
General Electric Co. to sell its biopharma business to Danaher for $21 billion in cash, plus pension obligations.
Many shades of meaning behind 'Medicare-for-all'
"Medicare-for-all" can mean different things to different people.
Big pharma probed over insulin prices by Senate
The probe comes as big pharma CEOs prepare to testify in front of the committee.
Medicare-for-all: The plan to expand what is financially broken to everyone
If you think health care is expensive now, wait until it’s free.
Trump admin proposes new regs on billion-dollar sunscreen industry
The proposed rules would prevent some ingredients from being sold without a prescription.
The subtle signs of heart issues in women
Dr. Kelly Powers' story

















